Overview Study of Cyclosporine in Post-LASIK Patients Status: Completed Trial end date: 2011-04-01 Target enrollment: Participant gender: Summary This study will evaluate the safety and efficacy of Cyclosporine 0.005% and 0.010% eye drops administered twice daily before and following LASIK surgery. Phase: Phase 2 Details Lead Sponsor: AllerganTreatments: CyclosporineCyclosporinsOphthalmic SolutionsTetrahydrozoline